Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
Pfizer charges $3.5M for its first FDA-approved gene therapy
Pfizer has gained its first FDA approval for a gene therapy, scoring with Beqvez for hemophilia B and will charge $3.5M for the one-time therapy.
Kevin Dunleavy
Apr 26, 2024 10:19am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am
Takeda joins growing list of drugmakers to leave trade group BIO
Apr 26, 2024 7:25am
Experts paint tough path ahead of Alnylam's key ATTR-CM readout
Apr 22, 2024 10:55am
AbbVie tops, J&J drops as physicians rank immunology players
Apr 19, 2024 7:30am
Pfizer focuses on long COVID in latest 'Dear Scientist' video
Apr 17, 2024 1:10pm